Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
LUMINOUS
LUMINOUS: Study to Observe the Effectiveness and Safety of Ranibizumab Through Individualized Patient Treatment and Associated Outcomes
1 other identifier
observational
30,490
40 countries
452
Brief Summary
This study will describe the long-term safety and effectiveness, treatment patterns,and patient reported quality of life associated with ranibizumab treatment in routine clinical practice for all approved indication included in the local product label.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2011
Longer than P75 for all trials
452 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2011
CompletedFirst Submitted
Initial submission to the registry
March 17, 2011
CompletedFirst Posted
Study publicly available on registry
March 21, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2016
CompletedMay 23, 2016
May 1, 2016
5.1 years
March 17, 2011
May 20, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Mean Visual Acuity (VA) and mean change in VA
3,6, and 12 months from the baseline visit, and annually thereafter
Incidence rate, relationship and severity of treatment emergent ocular and non-ocular adverse events
Defined time periods during study duration from FPFV until 30 days after LPLV
Mean visual acuity at quarterly intervals for the primary treated eye set
Quarterly intervals from baseline visit during study duration (5 years)
Secondary Outcomes (5)
Incidence rate of Adverse Events (AEs) and Serious Adverse Events (SAEs)
From the time the patient signed the informed consent until 30 days after study discontinuation
Number of ranibizumab injections administered per patient, per eye, and per person-year
annually
"National Eye Institute Visual Functioning Questionnaire-25" change from baseline
annually
Overall number of ranibizumab injections, number of visits, time interval between injections, duration of treatment, number of re-treatment, and reasons for treatment termination
Over time during study duration (5 years)
Change from baseline in National Eye Institute Visual Function Questionnaire 25 composite and sub-scale scores
Over time during study duration (5 years)
Study Arms (1)
Ranibizumab
Interventions
Eligibility Criteria
Outpatient ophthalmology Clinics
You may qualify if:
- Adult patients, within age limits as defined by local regulations and local product label, who have previously been treated with, who are currently being treated with or initiating treatment with ranibizumab for any approved indication included in the local product label
- Willing and able to provide informed written consent personally or by legal proxy
You may not qualify if:
- Simultaneous participation in a study that includes administration of any investigational drug or procedure
- Systemic or ocular treatment with any VEGF inhibitor other than ranibizumab in the 90 days prior to enrollment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (463)
Novartis Investigative Site
Buenos Aires, Argentina, Argentina
Novartis Investigative Site
Concepción del Uruguay, Argentina, Argentina
Novartis Investigative Site
Córdoba, Argentina, CP 5000, Argentina
Novartis Investigative Site
Guaymallén, Mendoza, Argentina, Argentina
Novartis Investigative Site
Rosario, Argentina, Argentina
Novartis Investigative Site
San Martin, Buenos Aires, Argentina, Argentina
Novartis Investigative Site
Santa Fe, Argentina, Argentina
Novartis Investigative Site
Lanús, Buenos Aires, B1824ABE, Argentina
Novartis Investigative Site
Mar del Plata, Buenos Aires, Argentina
Novartis Investigative Site
Rosario, Santa Fe Province, Argentina
Novartis Investigative Site
Buenos Aires, 1121, Argentina
Novartis Investigative Site
Buenos Aires, Argentina, Argentina
Novartis Investigative Site
Buenos Aires, CP1425, Argentina
Novartis Investigative Site
Caballito, C1437AVJ, Argentina
Novartis Investigative Site
Ciudad de Buenos Aires,, Argentina, Argentina
Novartis Investigative Site
La Plata, Argentina
Novartis Investigative Site
Santa Fe, Argentina, Argentina
Novartis Investigative Site
Chatswood, New South Wales, 2067, Australia
Novartis Investigative Site
Forster, New South Wales, 2428, Australia
Novartis Investigative Site
Kogarah, New South Wales, 2217, Australia
Novartis Investigative Site
Liverpool, New South Wales, 2170, Australia
Novartis Investigative Site
North Ryde, New South Wales, 2109, Australia
Novartis Investigative Site
Parramatta, New South Wales, 2150, Australia
Novartis Investigative Site
Strathfield, New South Wales, 2135, Australia
Novartis Investigative Site
Sydney, New South Wales, 2000, Australia
Novartis Investigative Site
Sydney, New South Wales, Australia, Australia
Novartis Investigative Site
Westmead, New South Wales, 2145, Australia
Novartis Investigative Site
Brisbane, Queensland, 4000, Australia
Novartis Investigative Site
South Brisbane, Queensland, 4101, Australia
Novartis Investigative Site
Southport, Queensland, 4125, Australia
Novartis Investigative Site
Adelaide, South Australia, 5000, Australia
Novartis Investigative Site
North Adelaide, South Australia, 5006, Australia
Novartis Investigative Site
Hobart, Tasmania, 7000, Australia
Novartis Investigative Site
South Launceston, Tasmania, 7249, Australia
Novartis Investigative Site
East Melbourne, Victoria, 3002, Australia
Novartis Investigative Site
Geelong, Victoria, 3220, Australia
Novartis Investigative Site
Glen Waverley, Victoria, VIC 3150, Australia
Novartis Investigative Site
Oakleigh, Victoria, 3166, Australia
Novartis Investigative Site
Linz, A-4020, Austria
Novartis Investigative Site
Vienna, A 1040, Austria
Novartis Investigative Site
Aalst, Belgium, 9300, Belgium
Novartis Investigative Site
Aarschot, Belgium, 3200, Belgium
Novartis Investigative Site
Bonheiden, 2820, Belgium
Novartis Investigative Site
Brussels, 1070, Belgium
Novartis Investigative Site
Dinant, 5500, Belgium
Novartis Investigative Site
Edegem, 2650, Belgium
Novartis Investigative Site
Ghent, 9000, Belgium
Novartis Investigative Site
Hasselt, 3500, Belgium
Novartis Investigative Site
Leuven, 3000, Belgium
Novartis Investigative Site
Mouscron, 7700, Belgium
Novartis Investigative Site
Namur, 5000, Belgium
Novartis Investigative Site
Nivelles, 1400, Belgium
Novartis Investigative Site
Reet, 2840, Belgium
Novartis Investigative Site
Yvoir, 5530, Belgium
Novartis Investigative Site
Zottegem, 9620, Belgium
Novartis Investigative Site
Goiânia, Goiás, 74210-010, Brazil
Novartis Investigative Site
Belo Horizonte, Minas Gerais, 30150-270, Brazil
Novartis Investigative Site
Rio de Janeiro, Rio de Janeiro, Brazil
Novartis Investigative Site
Porto Alegre, Rio Grande do Sul, Brazil
Novartis Investigative Site
Campinas, São Paulo, 13092-132, Brazil
Novartis Investigative Site
São Paulo, São Paulo, 01501-000, Brazil
Novartis Investigative Site
Calgary, Alberta, T2H0C8, Canada
Novartis Investigative Site
Victoria, British Columbia, V8V 4X3, Canada
Novartis Investigative Site
Miramichi, New Brunswick, E1V 1N9, Canada
Novartis Investigative Site
Halifax, Nova Scotia, B3H 2A5, Canada
Novartis Investigative Site
Brampton, Ontario, L6Y 0P6, Canada
Novartis Investigative Site
Downsview, Ontario, M5N 2V6, Canada
Novartis Investigative Site
East Brockville, Ontario, K6V 0V6, Canada
Novartis Investigative Site
London, Ontario, N6A 4G5, Canada
Novartis Investigative Site
Ottawa, Ontario, K1H 8L6, Canada
Novartis Investigative Site
Ottawa, Ontario, K1Z 8R2, Canada
Novartis Investigative Site
Scarborough Village, Ontario, M1R 3A6, Canada
Novartis Investigative Site
Toronto, Ontario, M5T 2S8, Canada
Novartis Investigative Site
Vaughan, Ontario, L4K 0C5, Canada
Novartis Investigative Site
Boisbriand, Quebec, J7H 1S6, Canada
Novartis Investigative Site
Barrie, ON L4M 4S, Canada
Novartis Investigative Site
Drummondville, J2B 5L4, Canada
Novartis Investigative Site
Hamilton, L9C 5R3, Canada
Novartis Investigative Site
Ontario, M1E 4A7, Canada
Novartis Investigative Site
Calama, Chile
Novartis Investigative Site
Beijing, Beijing Municipality, 100083, China
Novartis Investigative Site
Beijing, Beijing Municipality, 100730, China
Novartis Investigative Site
Beijing, Beijing Municipality, China
Novartis Investigative Site
Guangzhou, Guangdong, 510060, China
Novartis Investigative Site
Guiyang, Guizhou, 550004, China
Novartis Investigative Site
Wuhan, Hubei, 430060, China
Novartis Investigative Site
Jinan, Shandong, 250001, China
Novartis Investigative Site
Tianjin, Tianjin Municipality, 300020, China
Novartis Investigative Site
Kunming, Yunnan, 650021, China
Novartis Investigative Site
Beijing, 100034, China
Novartis Investigative Site
Beijing, 100730, China
Novartis Investigative Site
Beijing, China
Novartis Investigative Site
Changchun, 130041, China
Novartis Investigative Site
Chongqing, 400038, China
Novartis Investigative Site
Fujian, 361001, China
Novartis Investigative Site
Shanghai, 200080, China
Novartis Investigative Site
Shanghai, 200092, China
Novartis Investigative Site
Shanghai, China
Novartis Investigative Site
Ürümqi, 830000, China
Novartis Investigative Site
Barranquilla, Atlántico, Colombia
Novartis Investigative Site
Armenia, Quindío Department, Colombia
Novartis Investigative Site
Bogotá, Colombia
Novartis Investigative Site
Cali, Colombia
Novartis Investigative Site
Yopal, Colombia
Novartis Investigative Site
San José, Costa Rica, Costa Rica
Novartis Investigative Site
Brno-Bohunice, Czech Republic, 625 00, Czechia
Novartis Investigative Site
Hradec Králové, 500 05, Czechia
Novartis Investigative Site
Olomouc, 775 20, Czechia
Novartis Investigative Site
Ostrava-Poruba, 708 52, Czechia
Novartis Investigative Site
Pilsen, 304 60, Czechia
Novartis Investigative Site
Prague, 100 34, Czechia
Novartis Investigative Site
Prague, 12808, Czechia
Novartis Investigative Site
Prague, 16902, Czechia
Novartis Investigative Site
Ustri Nad Labem, 401 13, Czechia
Novartis Investigative Site
Santo Domingo, Republica Dominicana, Dominican Republic
Novartis Investigative Site
Ciudadela Kennedy, Guayaquil, Ecuador
Novartis Investigative Site
Cairo, Cairo Governorate, Egypt
Novartis Investigative Site
Giza, Egypt
Novartis Investigative Site
Poitiers, France, 86000, France
Novartis Investigative Site
Bordeaux, 33 000, France
Novartis Investigative Site
Créteil, 94000, France
Novartis Investigative Site
Dijon, 21034, France
Novartis Investigative Site
Lyon, 69317, France
Novartis Investigative Site
Melun, 77000, France
Novartis Investigative Site
Montargis, 45200, France
Novartis Investigative Site
Montauban, 82000, France
Novartis Investigative Site
Nantes, 44093, France
Novartis Investigative Site
Nice, 06200, France
Novartis Investigative Site
Paris, 75006, France
Novartis Investigative Site
Paris, 75010, France
Novartis Investigative Site
Paris, 75015, France
Novartis Investigative Site
Paris, 75940, France
Novartis Investigative Site
Reims, 51100, France
Novartis Investigative Site
Toulouse, 31059, France
Novartis Investigative Site
Vannes, 56000, France
Novartis Investigative Site
Augsburg, 86156, Germany
Novartis Investigative Site
Berlin, 10367, Germany
Novartis Investigative Site
Berlin, 10707, Germany
Novartis Investigative Site
Bonn, D-53105, Germany
Novartis Investigative Site
Cologne, 50924, Germany
Novartis Investigative Site
Dannenberg, 29451, Germany
Novartis Investigative Site
Hamburg, 22587, Germany
Novartis Investigative Site
Ingolstadt, 85049, Germany
Novartis Investigative Site
Lüdenscheid, 58515, Germany
Novartis Investigative Site
Münster, 48145, Germany
Novartis Investigative Site
Münster, 48149, Germany
Novartis Investigative Site
Neu-Ulm, 89231, Germany
Novartis Investigative Site
Osnabrück, 49076, Germany
Novartis Investigative Site
Regensburg, 93 047, Germany
Novartis Investigative Site
Rothenburg, 91541, Germany
Novartis Investigative Site
Schriesheim, 69198, Germany
Novartis Investigative Site
Tönisvorst, 47918, Germany
Novartis Investigative Site
Tübingen, 72076, Germany
Novartis Investigative Site
Alexandroupoli, Greece, 68100, Greece
Novartis Investigative Site
Athens, Greece, 11525, Greece
Novartis Investigative Site
Athens, Greece, 176 73, Greece
Novartis Investigative Site
Athens, GR, 106 72, Greece
Novartis Investigative Site
Heraklion - Crete, GR, 711 10, Greece
Novartis Investigative Site
Larissa, GR, 411 10, Greece
Novartis Investigative Site
Patra - RIO, GR, 265 04, Greece
Novartis Investigative Site
Rethymno, GR, 741 00, Greece
Novartis Investigative Site
Thessaloniki, GR, 546 29, Greece
Novartis Investigative Site
Athens, 10436, Greece
Novartis Investigative Site
Lamia, Phthiotis, 35100, Greece
Novartis Investigative Site
Guatemala City, Departamento de Guatemala, 01010, Guatemala
Novartis Investigative Site
Kowloon, Hong Kong, Hong Kong
Novartis Investigative Site
Budapest, 1133, Hungary
Novartis Investigative Site
Budapest, H-1083, Hungary
Novartis Investigative Site
Debrecen, 4012, Hungary
Novartis Investigative Site
Pécs, 7624, Hungary
Novartis Investigative Site
Szeged, 6720, Hungary
Novartis Investigative Site
Pātia, Bhudaneswar, 751 024, India
Novartis Investigative Site
Chennai, Tamil Nadu, 600 006, India
Novartis Investigative Site
Coimbatore, Tamil Nadu, 641 014, India
Novartis Investigative Site
Hyderabad, Telangana, 500 034, India
Novartis Investigative Site
Ahmedabad, 380009, India
Novartis Investigative Site
New Delhi, 110 029, India
Novartis Investigative Site
Dublin, 18, Ireland
Novartis Investigative Site
Dublin, Ireland
Novartis Investigative Site
Waterford, Ireland
Novartis Investigative Site
Haifa, 3339419, Israel
Novartis Investigative Site
Petah Tikva, 49100, Israel
Novartis Investigative Site
Tel Aviv, 64239, Israel
Novartis Investigative Site
Acquaviva delle Fonti, BA, 70021, Italy
Novartis Investigative Site
Cagliari, CA, 09124, Italy
Novartis Investigative Site
Genova, GE, 16132, Italy
Novartis Investigative Site
Alessandria, Italy
Novartis Investigative Site
Belluno, 32100, Italy
Novartis Investigative Site
Brescia, 25123, Italy
Novartis Investigative Site
Pisa, 56124, Italy
Novartis Investigative Site
Reggio Calabria, 89100, Italy
Novartis Investigative Site
Roma, 00161, Italy
Novartis Investigative Site
Roma, 00168, Italy
Novartis Investigative Site
Nagakute, Aichi-ken, 480-1195, Japan
Novartis Investigative Site
Nagoya, Aichi-ken, 462-0825, Japan
Novartis Investigative Site
Nagoya, Aichi-ken, 467-8602, Japan
Novartis Investigative Site
Nagoya, Aichi-ken, Japan
Novartis Investigative Site
Toyoake, Aichi-ken, 470-1192, Japan
Novartis Investigative Site
Aomori, Aomori, 030-8553, Japan
Novartis Investigative Site
Sakura, Chiba, 285-8741, Japan
Novartis Investigative Site
Matsuyama, Ehime, 790-8524, Japan
Novartis Investigative Site
Yoshida-gun, Fukui, 910-1193, Japan
Novartis Investigative Site
Fukuoka, Fukuoka, 812-8582, Japan
Novartis Investigative Site
Fukuoka, Fukuoka, 814-0180, Japan
Novartis Investigative Site
Kitakyushu, Fukuoka, 807-8556, Japan
Novartis Investigative Site
Fukushima, Fukushima, 960-1295, Japan
Novartis Investigative Site
Maebashi, Gunma, 371-8511, Japan
Novartis Investigative Site
Hiroshima, Hiroshima, 734-8551, Japan
Novartis Investigative Site
Sapporo, Hokkaido, 060-8543, Japan
Novartis Investigative Site
Sapporo, Hokkido, Japan
Novartis Investigative Site
Amagasaki, Hyōgo, 660-8550, Japan
Novartis Investigative Site
Kobe, Hyōgo, 657-0068, Japan
Novartis Investigative Site
Nishinomiya, Hyōgo, 663-8501, Japan
Novartis Investigative Site
Inashiki-gun, Ibaraki, 300-0395, Japan
Novartis Investigative Site
Tsukuba, Ibaraki, 305-8576, Japan
Novartis Investigative Site
Kanazawa, Ishikawa-ken, 920-8641, Japan
Novartis Investigative Site
Kita-gun, Kagawa-ken, 761-0793, Japan
Novartis Investigative Site
Ashigarakami-gun, Kanagawa, Japan
Novartis Investigative Site
Yokohama, Kanagawa, 232-0024, Japan
Novartis Investigative Site
Yokosuka, Kanagawa, 238-8558, Japan
Novartis Investigative Site
Yokohama, Kangawa, Japan
Novartis Investigative Site
Kyoto, Kyoto, 606-8507, Japan
Novartis Investigative Site
Tsu, Mie-ken, 514-8507, Japan
Novartis Investigative Site
Sendai, Miyagi, 981-8563, Japan
Novartis Investigative Site
Miyakonojō, Miyazaki, Japan
Novartis Investigative Site
Miyazaki, Miyazaki, 889-1692, Japan
Novartis Investigative Site
Suwa, Nagano, 392-8510, Japan
Novartis Investigative Site
Nagasaki, Nagasaki, 852-8501, Japan
Novartis Investigative Site
Kashihara, Nara, 634-8522, Japan
Novartis Investigative Site
Hirakata, Osaka, 573-1191, Japan
Novartis Investigative Site
Osaka, Osaka, 545-8586, Japan
Novartis Investigative Site
Sayama, Osaka, 589-8511, Japan
Novartis Investigative Site
Saitama, Saitama, 330-8503, Japan
Novartis Investigative Site
Saitama, Saitama, 338-8553, Japan
Novartis Investigative Site
Hamamatsu, Shizuoka, 430-8558, Japan
Novartis Investigative Site
Izunokuni, Shizuoka, 410-2295, Japan
Novartis Investigative Site
Shizuoka, Shizuoka, 422-8527, Japan
Novartis Investigative Site
Shimotsuka-gun, Tochigi, 321-0293, Japan
Novartis Investigative Site
Tokushima, Tokushima, 770-8503, Japan
Novartis Investigative Site
Bunkyo-ku, Tokyo, 113-8431, Japan
Novartis Investigative Site
Chiyoda-ku, Tokyo, 101-8309, Japan
Novartis Investigative Site
Mitaka, Tokyo, 181-8611, Japan
Novartis Investigative Site
Nerima-ku, Tokyo, Japan
Novartis Investigative Site
Shinjuku-ku, Tokyo, 160-0023, Japan
Novartis Investigative Site
Shinjuku-ku, Tokyo, 162-8666, Japan
Novartis Investigative Site
Urayasu, Tokyo, 279-0021, Japan
Novartis Investigative Site
Imizu-shi, Toyama, 939-0243, Japan
Novartis Investigative Site
Toyama, Toyama, 930-0194, Japan
Novartis Investigative Site
Yamagata, Yamagata, 990-9585, Japan
Novartis Investigative Site
Chūō, Yamanashi, 409-3898, Japan
Novartis Investigative Site
Akita, Japan
Novartis Investigative Site
Chiyoda-ku, 101-0062, Japan
Novartis Investigative Site
Ehime, Japan
Novartis Investigative Site
Gifu, Japan
Novartis Investigative Site
Hamamatsu, 430-0903, Japan
Novartis Investigative Site
Hokkaido, 080-0805, Japan
Novartis Investigative Site
Hokkaido, Japan
Novartis Investigative Site
Hyōgo, Japan
Novartis Investigative Site
Ishikawa, Japan
Novartis Investigative Site
Kagoshima, 890-0046, Japan
Novartis Investigative Site
Kagoshima, Japan
Novartis Investigative Site
Kakogawa-shi, 675-8611, Japan
Novartis Investigative Site
Kanagawa, Japan
Novartis Investigative Site
Kawasaki-shi, 211-0053, Japan
Novartis Investigative Site
Kitami-shi, 090-8666, Japan
Novartis Investigative Site
Koriyama-shi, 963-8585, Japan
Novartis Investigative Site
Kouchi, 783-8505, Japan
Novartis Investigative Site
Kyoto, 604-0837, Japan
Novartis Investigative Site
Miyagi, 980-8574, Japan
Novartis Investigative Site
Nagano, Japan
Novartis Investigative Site
Nagasaki, 852-8511, Japan
Novartis Investigative Site
Nantan-shi, 629-0392, Japan
Novartis Investigative Site
Osaka, Japan
Novartis Investigative Site
Ōtsu, 520-2192, Japan
Novartis Investigative Site
Saitama-ken, 336-0963, Japan
Novartis Investigative Site
Sanjo-shi, 955-0852, Japan
Novartis Investigative Site
Shizuoka, 420-0841, Japan
Novartis Investigative Site
Shunan-shi, 745-0017, Japan
Novartis Investigative Site
Tochigi, Japan
Novartis Investigative Site
Tokyo, 153-8515, Japan
Novartis Investigative Site
Tokyo, Japan
Novartis Investigative Site
Toyohashi, 441-8106, Japan
Novartis Investigative Site
Wakayama, 640-8558, Japan
Novartis Investigative Site
Yamagata, Japan
Novartis Investigative Site
Batu Caves, Selangor, 68100, Malaysia
Novartis Investigative Site
Kuala Lumpur, 50603, Malaysia
Novartis Investigative Site
Kuala Lumpur, 56000, Malaysia
Novartis Investigative Site
Kuala Lumpur, 59200, Malaysia
Novartis Investigative Site
Col. Lomas de Chapultepec, CP, 11000, Mexico
Novartis Investigative Site
Mexico City, Mexico City, 06030, Mexico
Novartis Investigative Site
Mexico City, Mexico City, 06800, Mexico
Novartis Investigative Site
Monterray, Nuevo León, 64710, Mexico
Novartis Investigative Site
Monterrey, Nuevo León, 64020, Mexico
Novartis Investigative Site
Mérida, Yucatán, Mexico
Novartis Investigative Site
Almere Stad, 1315 RA, Netherlands
Novartis Investigative Site
Amsterdam, 1071NT, Netherlands
Novartis Investigative Site
Tilburg, 5022 GC, Netherlands
Novartis Investigative Site
Panama City, Provincia de Panamá, 0819-12316, Panama
Novartis Investigative Site
Panama City, Provincia de Panamá, Panama
Novartis Investigative Site
Lima, Lima Province, LIMA 13, Peru
Novartis Investigative Site
San Borja, Lima region, 41, Peru
Novartis Investigative Site
San Isidro, Lima region, 27, Peru
Novartis Investigative Site
Bydgoszcz, 85-681, Poland
Novartis Investigative Site
Chojnice, 89-600, Poland
Novartis Investigative Site
Chorzów, 40-064, Poland
Novartis Investigative Site
Gdansk, 80-147, Poland
Novartis Investigative Site
Gda¿sk, 80-402, Poland
Novartis Investigative Site
Kalisz, 62 800, Poland
Novartis Investigative Site
Kielce, 25-514, Poland
Novartis Investigative Site
Krakow, 31-826, Poland
Novartis Investigative Site
Lodz, 93 357, Poland
Novartis Investigative Site
Olsztyn, 10-424, Poland
Novartis Investigative Site
Poznan, 61-693, Poland
Novartis Investigative Site
Warsaw, 02-097, Poland
Novartis Investigative Site
Warsaw, 04-141, Poland
Novartis Investigative Site
Wałbrzych, 58-300, Poland
Novartis Investigative Site
Wołomin, 05-200, Poland
Novartis Investigative Site
Coimbra, Portugal, 3000-354, Portugal
Novartis Investigative Site
Coimbra, Portugal, 3030-163, Portugal
Novartis Investigative Site
Aveiro, 3814-501, Portugal
Novartis Investigative Site
Leiria, 2410-104, Portugal
Novartis Investigative Site
Lisbon, 1500, Portugal
Novartis Investigative Site
Matosinhos Municipality, 4454-509, Portugal
Novartis Investigative Site
Santa Maria da Feira, 4520-211, Portugal
Novartis Investigative Site
Cheboksary, 428028, Russia
Novartis Investigative Site
Chelyabinsk, 454000, Russia
Novartis Investigative Site
Chita, 672038, Russia
Novartis Investigative Site
Irkutsk, 664033, Russia
Novartis Investigative Site
Kazan', 420012, Russia
Novartis Investigative Site
Khabarovsk, 680033, Russia
Novartis Investigative Site
Krasnodar, 350012, Russia
Novartis Investigative Site
Moscow, 105229, Russia
Novartis Investigative Site
Moscow, 10562, Russia
Novartis Investigative Site
Moscow, 119021, Russia
Novartis Investigative Site
Novosibirsk, 630096, Russia
Novartis Investigative Site
Penza, 440026, Russia
Novartis Investigative Site
Saint Petersburg, Russia, Russia
Novartis Investigative Site
Samara, 443079, Russia
Novartis Investigative Site
Saratov, 410028, Russia
Novartis Investigative Site
Surgut, 121359, Russia
Novartis Investigative Site
Tambov, 392000, Russia
Novartis Investigative Site
Tyumen, 625048, Russia
Novartis Investigative Site
Ufa, 450077, Russia
Novartis Investigative Site
Yakutsk, 677000, Russia
Novartis Investigative Site
Riyadh, 11426, Saudi Arabia
Novartis Investigative Site
Riyadh, 11462, Saudi Arabia
Novartis Investigative Site
Riyadh, 11662, Saudi Arabia
Novartis Investigative Site
Singapore, Singapore, 119074, Singapore
Novartis Investigative Site
Singapore, 168751, Singapore
Novartis Investigative Site
Singapore, 248649, Singapore
Novartis Investigative Site
Banksa Bystrica, Slovak Republic, 974 17, Slovakia
Novartis Investigative Site
Trebišov, Slovak Republic, 075 01, Slovakia
Novartis Investigative Site
Bratislava, Slovakia, 833 01, Slovakia
Novartis Investigative Site
Nové Zámky, Slovakia, 940 34, Slovakia
Novartis Investigative Site
Zvolen, Slovakia, 960 01, Slovakia
Novartis Investigative Site
Žilina, Slovakia, 01207, Slovakia
Novartis Investigative Site
Bratislava, 813 69, Slovakia
Novartis Investigative Site
Bratislava, 851 07, Slovakia
Novartis Investigative Site
Ljubljana, 1000, Slovakia
Novartis Investigative Site
Poprad, 058 01, Slovakia
Novartis Investigative Site
Ružomberok, 034 01, Slovakia
Novartis Investigative Site
Trenčín, SK-91171, Slovakia
Novartis Investigative Site
Novo Mesto, Slovenia, Slovenia
Novartis Investigative Site
Celje, 3000, Slovenia
Novartis Investigative Site
Ljubljana, 1000, Slovenia
Novartis Investigative Site
Maribor, 2000, Slovenia
Novartis Investigative Site
Seongnam-si, Gyeonggi-do, 13620, South Korea
Novartis Investigative Site
Suwon, Gyeonggi-do, 443-721, South Korea
Novartis Investigative Site
Seoul, Korea, 05505, South Korea
Novartis Investigative Site
Seoul, Korea, 110 744, South Korea
Novartis Investigative Site
Busan, 612-896, South Korea
Novartis Investigative Site
Daegu, 705-703, South Korea
Novartis Investigative Site
Pusan, 602-739, South Korea
Novartis Investigative Site
Seoul, 120-752, South Korea
Novartis Investigative Site
Seoul, 130-872, South Korea
Novartis Investigative Site
Seoul, 137-701, South Korea
Novartis Investigative Site
Seoul, 150-950, South Korea
Novartis Investigative Site
Seoul, South Korea
Novartis Investigative Site
Taegu, 700 - 721, South Korea
Novartis Investigative Site
Málaga, Andalusia, 29010, Spain
Novartis Investigative Site
León, Castille and León, 24071, Spain
Novartis Investigative Site
Salamanca, Castille and León, 32007, Spain
Novartis Investigative Site
Valladolid, Castille and León, 47011, Spain
Novartis Investigative Site
Barcelona, Catalonia, 08025, Spain
Novartis Investigative Site
Sant Cugat del Vallès, Catalonia, 08190, Spain
Novartis Investigative Site
Tarragona, Catalonia, 43005, Spain
Novartis Investigative Site
Lugo, Galicia, 27003, Spain
Novartis Investigative Site
Logroño, Hospital La Rioja Provincia, 26001, Spain
Novartis Investigative Site
Murcia, Murcia, 30003, Spain
Novartis Investigative Site
Valencia, Valencia, 46015, Spain
Novartis Investigative Site
Valencia, Valencia, 46026, Spain
Novartis Investigative Site
Zaragoza, Zaragoza, 50009, Spain
Novartis Investigative Site
Barcelona, 08025, Spain
Novartis Investigative Site
Burgos, 09006, Spain
Novartis Investigative Site
Granollers, 08402, Spain
Novartis Investigative Site
Madrid, 28008, Spain
Novartis Investigative Site
Madrid, 28010, Spain
Novartis Investigative Site
Madrid, 28040, Spain
Novartis Investigative Site
Madrid, 28041, Spain
Novartis Investigative Site
Madrid, 28805, Spain
Novartis Investigative Site
Zaragoza, 50009, Spain
Novartis Investigative Site
Ankara, Turkey, 06500, Turkey (Türkiye)
Novartis Investigative Site
Altindag / Ankara, 06590, Turkey (Türkiye)
Novartis Investigative Site
Ankara, 06100, Turkey (Türkiye)
Novartis Investigative Site
Mecidiyekoy/Istanbul, 34394, Turkey (Türkiye)
Novartis Investigative Site
Dnipropetrovsk, 49027, Ukraine
Novartis Investigative Site
Kyiv, 03065, Ukraine
Novartis Investigative Site
Luhansk, 91055, Ukraine
Novartis Investigative Site
Odesa, Ukraine
Novartis Investigative Site
Truro, Cornwall, TR1 3LJ, United Kingdom
Novartis Investigative Site
Durham, County Durham, DH1 5TW, United Kingdom
Novartis Investigative Site
Torquay, Devon,, TQ2 7AA, United Kingdom
Novartis Investigative Site
Bolton, England, BL4 0JR, United Kingdom
Novartis Investigative Site
Solihull, England, B91 2JL, United Kingdom
Novartis Investigative Site
Southampton, England, SO16 6YD, United Kingdom
Novartis Investigative Site
Wakefield, England, WF1 3JS, United Kingdom
Novartis Investigative Site
Belfast, Essex, BT12 6BA, United Kingdom
Novartis Investigative Site
Romford, Essex, RM7 0AG, United Kingdom
Novartis Investigative Site
Cheltenham, Gloucestershire, GL53 7AN, United Kingdom
Novartis Investigative Site
Blackburn, Lancashire, BB2 3HH, United Kingdom
Novartis Investigative Site
Hull, Lancashire, HU3 2JZ, United Kingdom
Novartis Investigative Site
Leicester, Lancashire, LE1 5WW, United Kingdom
Novartis Investigative Site
Coventry, London, CV2 2DX, United Kingdom
Novartis Investigative Site
Derby, London, DE22 3NE, United Kingdom
Novartis Investigative Site
Leytonstone, London, E11 1NR, United Kingdom
Novartis Investigative Site
Oxford, Oxfordshire, OX3 9DU, United Kingdom
Novartis Investigative Site
Sheffield, South Yorkshire, S10 2JF, United Kingdom
Novartis Investigative Site
Stoke-on-Trent, Staffordshire, ST4 7LN, United Kingdom
Novartis Investigative Site
Frimley, Surrey, GU16 7UJ, United Kingdom
Novartis Investigative Site
Guildford, Surrey, GU2 7XX, United Kingdom
Novartis Investigative Site
Worcester, UK, WR5 1DD, United Kingdom
Novartis Investigative Site
London, United Kingdom, EC1V 2PD, United Kingdom
Novartis Investigative Site
Bradford, West Yorkshire, BD9 6RJ, United Kingdom
Novartis Investigative Site
Bedford, MK429DJ, United Kingdom
Novartis Investigative Site
Birmingham, B18 7QU, United Kingdom
Novartis Investigative Site
Bristol, BS1 2LX, United Kingdom
Novartis Investigative Site
Cardiff, CF14 4XN, United Kingdom
Novartis Investigative Site
Cheshire, CW1 4QJ, United Kingdom
Novartis Investigative Site
Colchester, CO3 3NB, United Kingdom
Novartis Investigative Site
Inverness, IV2 3UJ, United Kingdom
Novartis Investigative Site
Kent, CT1 3NG, United Kingdom
Novartis Investigative Site
Leeds, LS9 7TF, United Kingdom
Novartis Investigative Site
Liverpool, L9 7AL, United Kingdom
Novartis Investigative Site
London, NW1 5QH, United Kingdom
Novartis Investigative Site
London, NW3 2QG, United Kingdom
Novartis Investigative Site
London, SE5 9RS, United Kingdom
Novartis Investigative Site
Maidstone, ME16 9QQ, United Kingdom
Novartis Investigative Site
Manchester, M13 9WL, United Kingdom
Novartis Investigative Site
Merseyside, CH49 5PE, United Kingdom
Novartis Investigative Site
Merseyside, L7 8PX, United Kingdom
Novartis Investigative Site
Middlesbrough, TS4 3BW, United Kingdom
Novartis Investigative Site
Newport, P030 5TG, United Kingdom
Novartis Investigative Site
Portsmouth, PO6 3LY, United Kingdom
Novartis Investigative Site
Southend, SS0 0RY, United Kingdom
Novartis Investigative Site
Sunderland, SR2 9HP, United Kingdom
Novartis Investigative Site
Uxbridge, UB8 3NN, United Kingdom
Novartis Investigative Site
Wolverhampton, WV10 0QP, United Kingdom
Novartis Investigative Site
York, YO31 8HE, United Kingdom
Novartis Investigative Site
Porlamar Local 02, Isla Margarita, Venezuela
Novartis Investigative Site
Caracas, Venezuela
Novartis Investigative Site
Caracas, Piso 6, Ofic. 607, Venezuela
Novartis Investigative Site
Santa Paula, Venezuela
Novartis Investigative Site
Torre Venezuela, Piso 1, Venezuela
Related Publications (5)
Holz FG, Minnella AM, Tuli R, Yoganathan P, Parikh S, Hamilton R; LUMINOUS study group. Ranibizumab treatment patterns in prior ranibizumab-treated neovascular age-related macular degeneration patients: Real-world outcomes from the LUMINOUS study. PLoS One. 2020 Dec 30;15(12):e0244183. doi: 10.1371/journal.pone.0244183. eCollection 2020.
PMID: 33378369DERIVEDLeys AM, Ramboer E, Favreau M, Denhaerynck K, MacDonald K, Abraham I, Brie H. Long-Term Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration: A Belgian Subanalysis from the Global Real-World LUMINOUSTM Study. Clin Ophthalmol. 2020 Jun 2;14:1473-1481. doi: 10.2147/OPTH.S242547. eCollection 2020.
PMID: 32581505DERIVEDPearce I, Clemens A, Brent MH, Lu L, Gallego-Pinazo R, Minnella AM, Creuzot-Garcher C, Spital G, Sakamoto T, Dunger-Baldauf C, McAllister IL; all the LUMINOUS study investigators. Real-world outcomes with ranibizumab in branch retinal vein occlusion: The prospective, global, LUMINOUS study. PLoS One. 2020 Jun 18;15(6):e0234739. doi: 10.1371/journal.pone.0234739. eCollection 2020.
PMID: 32555630DERIVEDMitchell P, Sheidow TG, Farah ME, Mahmood S, Minnella AM, Eter N, Eldem B, Al-Dhibi H, Macfadden W, Parikh S, Dunger-Baldauf C, Mahgoub MM, Schmidt-Erfurth U; LUMINOUS study investigators. Effectiveness and safety of ranibizumab 0.5 mg in treatment-naive patients with diabetic macular edema: Results from the real-world global LUMINOUS study. PLoS One. 2020 Jun 3;15(6):e0233595. doi: 10.1371/journal.pone.0233595. eCollection 2020.
PMID: 32492069DERIVEDSchmidt-Erfurth U, Chong V, Loewenstein A, Larsen M, Souied E, Schlingemann R, Eldem B, Mones J, Richard G, Bandello F; European Society of Retina Specialists. Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA). Br J Ophthalmol. 2014 Sep;98(9):1144-67. doi: 10.1136/bjophthalmol-2014-305702.
PMID: 25136079DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Novartis Pharmaceuticals
Novartis Pharmaceuticals
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 17, 2011
First Posted
March 21, 2011
Study Start
March 1, 2011
Primary Completion
April 1, 2016
Study Completion
April 1, 2016
Last Updated
May 23, 2016
Record last verified: 2016-05